Nancy's Shared Resources

How Early Is Early in Psoriatic Arthritis? Insights on Treatment Timing
Despite major advances in biologic and targeted synthetic therapies, the optimal timing for treatment initiation in psoriatic arthritis (PsA) remains...

What Patients With Psoriatic Arthritis Say Matters Most
This mixed-methods study examined how patients and clinicians prioritize aspects of psoriatic arthritis (PsA), highlighting key differences that can impact...

Gut Microbiota and Psoriatic Arthritis: A New Frontier in Diagnosis and Treatment
The diagnosis of psoriatic arthritis (PsA) is frequently delayed due to variable clinical presentations and the lack of specific biomarkers....

When Psoriatic Arthritis Persists: Treatment for Complex Cases
The treatment of psoriatic arthritis (PsA) has evolved from NSAIDs and csDMARDs to biologics and targeted synthetic DMARDs (tsDMARDs), enabling...

Early Diagnosis of Psoriatic Arthritis Linked to Better Long-Term Outcomes
This study analyzed data from more than 700 newly diagnosed, DMARD-naïve patients with psoriatic arthritis (PsA) to evaluate the impact...

SOX5 Autoantibodies Emerge as Potential Biomarker for Psoriatic Disease Subgroups
This study identified a novel class of autoantibodies in psoriatic arthritis (PsA) that target SOX-D transcription factors—specifically SOX5, SOX6, and...